Type 2 Diabetes Clinical Trial
In Canada, there is a fast-growing population with diabetes, and the majority of diabetes
cases are type 2 diabetes (T2D). Diabetes and its complications, such as cardiovascular
diseases, eye disease and foot disease, impair the quality of life and life expectancy.
Chinese are the second largest visible minority in Canada. The diabetes incidence increased
much more rapidly in the Canadian population of Chinese origin compared with that of
European origin in past decades. Cultural factors are very likely to affect individual
behaviour in diabetes treatment. Both international and Canadian diabetes organizations have
recognized the importance of taking into account the cultural background and individual
preferences in diabetes treatment.
However, there lacks cultural relevant nutritional recommendations or guidelines for Chinese
Canadians except some literally translated materials which may not be culturally relevant.
In order to fill the gap, the investigators have developed a Chinese menu plan that includes
commonly consumed Chinese dishes with nutrients breakdown and cooking tips to provide
guidance for patients in their daily meal planning. This menu plan is a cultural translation
of the Canadian nutritional guidelines, which is urgently needed among Chinese immigrants
with T2D in Edmonton, according to our previous needs assessment.
In this pilot test, the investigators will examine the feasibility and effectiveness of the
Chinese menu plan. Twenty Chinese with T2D in Edmonton will be recruited to use the menu
plan for 3 consecutive months and relevant indices of T2D will be tested as indicators of
effectiveness. Feedback from participants will be obtained through one-on-one interviews and
appropriate modifications will be made to the menu plan.
1. Objectives
The objectives of this study are to assess the feasibility of the Chinese menu plan in
Chinese immigrants with type 2 diabetes (T2D), and to assess the effectiveness of the
menu plan in terms of nutrient intakes, glycemic control, weight management and other
biochemical indices.
2. Background
2.1 Prevalence of diabetes
According to Statistics Canada, the diabetes population in 2010 increased by 39.0%
compared with that in 2005, while the total population increased by 4.8% in the five
years. Diabetes is the sixth leading cause of death in Canada and it brings
complications such as cardiovascular, renal, foot and eye diseases, which cause
disabilities and reduction in life expectancy. T2D comprises 90% of diabetes population
worldwide, and is largely a result of excess body weight and physical inactivity.
Ethnic Chinese is the second largest visible minority in Canada, and comprises 3.9% and
5.2% of the total population of Canada and of Edmonton, respectively. It has been
reported that Chinese Canadians are at high risk of diabetes. This warrants more
attention to diabetes management among ethnic Chinese in Canada.
2.2 Importance of culturally relevant interventions
Self-care during chronic disease is better facilitated when cultural competence and
congruency is incorporated in the management approach. Both international and Canadian
guidelines recognize the importance of individualizing treatment based on culture.
Chinese Canadians especially the first generations, usually have distinct dietary
pattern from the Western diet in terms of food selections and combinations, cooking
methods, and the number of dishes per meal, etc. So a general Canadian menu plan is not
applicable to ethnic Chinese. Although dietary acculturation happens following
immigration, which results in a mixture of traditional and Western diet and cooking
techniques in immigrants, traditional diet still takes larger proportion. Diabetes
research on Chinese Canadians is scarce and so is Chinese-culture specific nutritional
guidelines in Canada. We have developed a culturally relevant menu plan for Chinese
Canadians based on the needs assessment and recommendations from Canadian Diabetes
Association guidelines and Eating Well with Canada's Food Guide. This pilot study is to
test the effectiveness of the menu plan, which can become a practical tool for diabetes
self-management in the ethnic Chinese population.
3. Methods and procedures
We will recruit 20 Chinese individuals with T2D in Edmonton to the pilot test. Inclusion
criteria are: ≥ 35 years of age; diagnosed with T2D or prediabetes; beginning hemoglobin A1C
≥ 6.0%; treatment with lifestyle, and/or oral hypoglycemic medications or insulin; Chinese
origin; able to read and write Chinese or English. Exclusion criteria are: severe
gastrointestinal or renal problems that would preclude them eating according to the
Nutrition Therapy Guidelines for Diabetes.
3.1 Baseline assessment
Before the 12-week intervention, baseline assessment will be conducted on all participants,
including measurement of A1C, height, weight, waist circumference and body composition.
Fasting blood samples will be collected for lipid profile measurement. Demographic
characteristics, diabetes treatment, self-care activities, physical activity and perceived
dietary adherence will be assessed using questionnaires. Participants will three-day food
records for dietary intake analysis.
3.2 Adoption
Participants will be asked to follow the menu plan for 12 weeks and keep weekly records of
their use of the menu plan. Goal setting will be applied to facilitate adoption. During the
first four weeks, the study coordinator will hold one-on-one weekly interviews with each
participant to provide feedback and education about the menu plan. Obstacles and strategies
will be discussed. During the last eight weeks, only one interview per month will be
scheduled to address any problems that participants may have and to help monitor their goal
achievement. Participants will be asked to complete another 3-day food record during the
last week of the test.
3.3 Final assessment
After study completion, A1C, weight, waist circumference and body composition will be
measured within 1 week. A fasting blood sample will be collected to measure lipid profile.
Some of the baseline questionnaires including diabetes treatment and perceived dietary
adherence will be repeated, and an exit survey will be completed. The final three-day food
records will be collected from participants. Focus groups will be conducted to gather
information on participants' experiences and perceived benefits of, and barriers and
facilitators to following the menu plan. Feedback will be collected as one of the references
for possible modification of the menu plan.
3.4 Follow-up
Email or telephone follow-up will be conducted 2 months after study completion to document
whether participants continue to use the menu plan. This will be one of the indicators for
the long-term feasibility of the menu plan.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05219994 -
Targeting the Carotid Bodies to Reduce Disease Risk Along the Diabetes Continuum
|
N/A | |
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Completed |
NCT02284893 -
Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone
|
Phase 3 | |
| Completed |
NCT04274660 -
Evaluation of Diabetes and WELLbeing Programme
|
N/A | |
| Active, not recruiting |
NCT05887817 -
Effects of Finerenone on Vascular Stiffness and Cardiorenal Biomarkers in T2D and CKD (FIVE-STAR)
|
Phase 4 | |
| Active, not recruiting |
NCT05566847 -
Overcoming Therapeutic Inertia Among Adults Recently Diagnosed With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Completed |
NCT04965506 -
A Study of IBI362 in Chinese Patients With Type 2 Diabetes
|
Phase 2 | |
| Recruiting |
NCT06115265 -
Ketogenic Diet and Diabetes Demonstration Project
|
N/A | |
| Active, not recruiting |
NCT03982381 -
SGLT2 Inhibitor or Metformin as Standard Treatment of Early Stage Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT04971317 -
The Influence of Simple, Low-Cost Chemistry Intervention Videos: A Randomized Trial of Children's Preferences for Sugar-Sweetened Beverages
|
N/A | |
| Completed |
NCT04496154 -
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
|
N/A | |
| Completed |
NCT04023539 -
Effect of Cinnamomum Zeylanicum on Glycemic Levels of Adult Patients With Type 2 Diabetes
|
N/A | |
| Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
| Enrolling by invitation |
NCT05530356 -
Renal Hemodynamics, Energetics and Insulin Resistance: A Follow-up Study
|
||
| Completed |
NCT03960424 -
Diabetes Management Program for Hispanic/Latino
|
N/A | |
| Completed |
NCT04097600 -
A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (D) Semaglutide Tablets
|
Phase 1 | |
| Completed |
NCT05378282 -
Identification of Diabetic Nephropathy Biomarkers Through Transcriptomics
|
||
| Active, not recruiting |
NCT06010004 -
A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03653091 -
Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes
|
N/A |